In this community, professionals share information regarding the clinical, programmatic and community-oriented aspects of early diagnosis, treatment and prevention of multi-drug-resistant tuberculosis (MDR-TB). Members also use this forum to promote universal access to quality care for MDR-TB.
[Please forward and excuse cross-posting] All, Please find below and online an open letter from MSF to Johnson & Johnson (J&J) regarding the drug bedaquiline calling for J&J to lower the price and provide a non-exclusive license to ensure affordable access and a sustained supply. Bedaquiline is essential for treating-- ... read more
Dear all, I believe the IPD MA published in the Lancet and circulated here is what has informed the U.S. Centers for Disease Control and Prevention/ American Thoracic Society (ATS)/ Infectious Diseases Society of America (IDSA)/ European Respiratory Society (ERS) MDR-TB treatment guidelines expected to come out later this year. ... read more
Dear David Your question is real and continual issue in our settings. MSH has done some work in Ethiopia and we can link you to our colleagues at MSH Ethiopia Countries office. Please send a mail to firstname.lastname@example.org for further discussion. Best regards *Alaine Umubyeyi Nyaruhirira, MpH, PHD* *Senior Laboratory ... read more
Please see this call for papers by PLOS Medicine, ahead of the UN High Level Meeting on TB next month: https://blogs.plos.org/speakingofmedicine/2018/08/28/plos-medicine-special-is... This issue is focused on new tools for diagnosis, treatment and elimination. Best Madhu read more
Malawi-Liverpool-Wellcome Trust Clinical Research ProgrammeWork Locations
Ministry of Health, ZambiaWork Locations
General HospitalWork Locations